Polaris Venture Management Co V’s Cardlytics CDLX Stock Holding History

Polaris Venture Management Co V’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$12.6M	–	11
2019 Q4	$12.6M	Sell	20,000 -130,807	-87%	-$64M	9.14%	3
2019 Q3	$50.5M	Sell	150,807 -76,927	-34%	-$24.7M	28.72%	2
2019 Q2	$59.2M	Sell	227,734 -27,529	-11%	-$5.51M	46.48%	1
2019 Q1	$42.5M	Hold	255,263	–	–	35.95%	1
2018 Q4	$27.6M	Hold	255,263	–	–	29.51%	1
2018 Q3	$63.9M	Sell	255,263 -8,363	-3%	-$1.8M	32%	1
2018 Q2	$57.4M	Hold	263,626	–	–	31.26%	1
2018 Q1	$38.6M	Buy	+263,626	New	+$44.6M	21.99%	2

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Polaris Venture Management Co V's CDLX Position: Q1 2020 in Review

Polaris Venture Management Co V sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 20,000 shares — an estimated $12.6M sold.

Polaris Venture Management Co V first reported a position in CDLX in Q1 2018 and held it in 8 quarters. The position peaked at $63.9M in Q3 2018. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

Polaris Venture Management Co V reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
Polaris Venture Management Co V sold 20,000 Cardlytics shares in Q1 2020, an estimated $12.6M.
Polaris Venture Management Co V first reported a position in Cardlytics in Q1 2018 and held it in 8 quarters.
Polaris Venture Management Co V's Cardlytics position peaked at $63.9M in Q3 2018.
142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Polaris Venture Management Co V's 13F filing for Q1 2020, filed 14 May 2020.